L. J. Rubin, Primary Pulmonary Hypertension, New England Journal of Medicine, vol.336, issue.2, pp.111-117, 1997.
DOI : 10.1056/NEJM199701093360207

M. Humbert, Cellular and molecular pathobiology of pulmonary arterial hypertension, Journal of the American College of Cardiology, vol.43, issue.12, pp.13-24, 2004.
DOI : 10.1016/j.jacc.2004.02.029

S. Eddahibi, Cross Talk Between Endothelial and Smooth Muscle Cells in Pulmonary Hypertension: Critical Role for Serotonin-Induced Smooth Muscle Hyperplasia, Circulation, vol.113, issue.15, pp.1857-1864, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.591321

A. Armulik, A. Abramsson, and C. Betsholtz, Endothelial/Pericyte Interactions, Circulation Research, vol.97, issue.6, pp.512-523, 2005.
DOI : 10.1161/01.RES.0000182903.16652.d7

L. Dewachter, Angiopoietin/Tie2 Pathway Influences Smooth Muscle Hyperplasia in Idiopathic Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.9, pp.1025-1033, 2006.
DOI : 10.1164/rccm.200602-304OC

C. J. Powers, S. W. Mcleskey, and A. Wellstein, Fibroblast growth factors, their receptors and signaling, Endocrine Related Cancer, vol.7, issue.3, pp.165-197, 2000.
DOI : 10.1677/erc.0.0070165
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.323.4337

M. Presta, Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis, Cytokine & Growth Factor Reviews, vol.16, issue.2, pp.159-178, 2005.
DOI : 10.1016/j.cytogfr.2005.01.004

S. S. Arcot, J. A. Fagerland, D. W. Lipke, M. N. Gillespie, and J. W. Olson, Basic Fibroblast Growth Factor Alterations During Development of Monocrotaline-Induced Pulmonary Hypertension in Rats, Growth Factors, vol.38, issue.2, pp.121-130, 1995.
DOI : 10.3109/10408449209146311

A. J. Potgens, H. R. Westphal, R. M. De-waal, and D. J. Ruiter, The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis, Biol. Chem. Hoppe-Seyler, vol.376, pp.57-70, 1995.

K. Smith, Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor , epidermal growth factor receptor and survival, Annals of Oncology, vol.10, issue.6, pp.707-713, 1999.
DOI : 10.1023/A:1008303614441

M. Benezra, I. Vlodavsky, R. Ishai-michaeli, G. Neufeld, and R. Bar-shavit, Thrombininduced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix, Blood, vol.81, pp.3324-3331, 1993.

J. A. Buczek-thomas and M. A. Nugent, Elastase-mediated Release of Heparan Sulfate Proteoglycans from Pulmonary Fibroblast Cultures: A MECHANISM FOR BASIC FIBROBLAST GROWTH FACTOR (bFGF) RELEASE AND ATTENUATION OF bFGF BINDING FOLLOWING ELASTASE-INDUCED INJURY, Journal of Biological Chemistry, vol.274, issue.35, pp.25167-25172, 1999.
DOI : 10.1074/jbc.274.35.25167

S. J. George, J. L. Johnson, M. A. Smith, J. , and C. L. , Plasmin-Mediated Fibroblast Growth Factor-2 Mobilisation Supports Smooth Muscle Cell Proliferation in Human Saphenous Vein, Journal of Vascular Research, vol.38, issue.5, pp.492-501, 2001.
DOI : 10.1159/000051082

K. Thompson and M. Rabinovitch, Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular matrix-bound basic fibroblast growth factor, Journal of Cellular Physiology, vol.94, issue.3, pp.495-505, 1996.
DOI : 10.1002/(SICI)1097-4652(199603)166:3<495::AID-JCP4>3.0.CO;2-K

C. A. Dionne, M. Jaye, and J. Schlessinger, Structural diversity and binding of FGF receptors, 1991.

Y. Inoue, Basic Fibroblast Growth Factor and Its Receptors in Idiopathic Pulmonary Fibrosis and Lymphangioleiomyomatosis, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.5, pp.765-773, 2002.
DOI : 10.1164/rccm.2010014

P. P. Powell, Differential Expression of Fibroblast Growth Factor Receptors 1 to 4 and Ligand Genes in Late Fetal and Early Postnatal Rat Lung, American Journal of Respiratory Cell and Molecular Biology, vol.19, issue.4, pp.563-572, 1998.
DOI : 10.1165/ajrcmb.19.4.2994

I. Sher, Identification of Residues Important Both for Primary Receptor Binding and Specificity in Fibroblast Growth Factor-7, Journal of Biological Chemistry, vol.275, issue.45, pp.34881-34886, 2000.
DOI : 10.1074/jbc.M003293200

J. I. Benisty, Elevated Basic Fibroblast Growth Factor Levels in Patients With Pulmonary Arterial Hypertension, Chest, vol.126, issue.4, pp.1255-1261, 2004.
DOI : 10.1378/chest.126.4.1255

S. Wedgwood, Fibroblast Growth Factor-2 Expression Is Altered in Lambs With Increased Pulmonary Blood Flow and Pulmonary Hypertension, Pediatric Research, vol.288, issue.1, pp.32-36, 2007.
DOI : 10.1203/01.pdr.0000250013.77008.28

A. Molteni, W. F. Ward, C. H. Ts-'ao, and J. M. Hinz, Monocrotaline-induced cardiopulmonary injury in rats, Biochemical Pharmacology, vol.38, issue.15, pp.2411-2419, 1989.
DOI : 10.1016/0006-2952(89)90084-1

A. Molteni, W. F. Ward, C. H. Ts-'ao, and N. H. Solliday, Monocrotaline-Induced Cardiopulmonary Damage in Rats: Amelioration by the Angiotensin-Converting Enzyme Inhibitor CL242817, Experimental Biology and Medicine, vol.182, issue.4, pp.483-493, 1986.
DOI : 10.3181/00379727-182-42370

A. Molteni, W. F. Ward, C. H. Ts-'ao, and N. H. Solliday, Monocrotaline pneumotoxicity in mice, Virchows Archiv B Cell Pathology Including Molecular Pathology, vol.9, issue.1, pp.149-155, 1989.
DOI : 10.1007/BF02899076

L. C. Pan, D. W. Wilson, M. W. Lame, A. D. Jones, and H. J. Segall, COR Pulmonale Is Caused by Monocrotaline and Dehydromonocrotaline, but Not by Glutathione or Cysteine Conjugates of Dihydropyrrolizine, Toxicology and Applied Pharmacology, vol.118, issue.1, pp.87-97, 1993.
DOI : 10.1006/taap.1993.1013

A. Baird, L. , and N. , Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular response, Biochemical and Biophysical Research Communications, vol.142, issue.2, pp.428-435, 1987.
DOI : 10.1016/0006-291X(87)90292-0

I. Vlodavsky, Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix., Proceedings of the National Academy of Sciences, vol.84, issue.8, pp.2292-2296, 1987.
DOI : 10.1073/pnas.84.8.2292

A. Cucina, Autocrine production of basic fibroblast growth factor translated from novel synthesized mRNA mediates thrombin-induced mitogenesis in smooth muscle cells, Cell Biochemistry and Function, vol.97, issue.1, pp.39-46, 2002.
DOI : 10.1002/cbf.938

T. H. Lee, Heterogeneity of Capillary Endothelial Cells for Basic Fibroblast Growth Factor-Induced Paracrine Signaling, Endothelium, vol.9, issue.3, pp.191-203, 2006.
DOI : 10.1007/BF00327997

C. Billottet, N. Elkhatib, J. P. Thiery, and J. Jouanneau, Targets of Fibroblast Growth Factor 1 (FGF-1) and FGF-2 Signaling Involved in the Invasive and Tumorigenic Behavior of Carcinoma Cells, Molecular Biology of the Cell, vol.15, issue.10, pp.4725-4734, 2004.
DOI : 10.1091/mbc.E04-04-0336

J. L. Gabrilove, Angiogenic Growth Factors: Autocrine and Paracrine Regulation of Survival in Hematologic Malignancies, The Oncologist, vol.6, issue.90005, pp.4-7, 2001.
DOI : 10.1634/theoncologist.6-suppl_5-4

R. Giavazzi, Distinct Role of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor on Tumor Growth and Angiogenesis, The American Journal of Pathology, vol.162, issue.6, pp.1913-1926, 2003.
DOI : 10.1016/S0002-9440(10)64325-8

M. Nguyen, Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients With a Wide Spectrum of Cancers, JNCI Journal of the National Cancer Institute, vol.86, issue.5, pp.356-361, 1994.
DOI : 10.1093/jnci/86.5.356

C. Guignabert, Serotonin Transporter Inhibition Prevents and Reverses Monocrotaline-Induced Pulmonary Hypertension in Rats, Circulation, vol.111, issue.21, pp.2812-2819, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.524926
URL : https://hal.archives-ouvertes.fr/inserm-00499643

R. J. Van-suylen, J. F. Smits, and M. J. Daemen, Pulmonary Artery Remodeling Differs in Hypoxia- and Monocrotaline-induced Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.157, issue.5, pp.1423-1428, 1998.
DOI : 10.1164/ajrccm.157.5.9709050

O. E. Pardo, FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKC??, B-Raf and S6K2, The EMBO Journal, vol.63, issue.13, pp.3078-3088, 2006.
DOI : 10.1074/jbc.271.52.33592

D. Xiao, Inhibition of fibroblast growth factor 2-induced apoptosis involves survivin expression, protein kinase C?? activation and subcellular translocation of Smac in human small cell lung cancer cells, Acta Biochimica et Biophysica Sinica, vol.40, issue.4, pp.297-303, 2008.
DOI : 10.1111/j.1745-7270.2008.00401.x

S. H. Kennedy, Basic FGF regulates research article The Journal of Clinical Investigation http, p.523, 1997.

W. Holnthoner, M. Kerenyi, M. Groger, F. Kratochvill, and P. Petzelbauer, Regulation of matrilysin expression in endothelium by fibroblast growth factor-2, Biochemical and Biophysical Research Communications, vol.342, issue.3, pp.725-733, 2006.
DOI : 10.1016/j.bbrc.2006.02.011

G. Pintucci, Induction of stromelysin-1 (MMP-3) by fibroblast growth factor-2 (FGF-2) in FGF-2?/? microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK-1/2), Journal of Cellular Biochemistry, vol.16, issue.5, pp.1015-1025, 2003.
DOI : 10.1002/jcb.10721

D. Besser, M. Presta, and Y. Nagamine, Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts, Cell Growth Differ, vol.6, pp.1009-1017, 1995.

D. Ribatti, In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2, J. Cell Sci, vol.112, pp.4213-4221, 1999.

M. U. Naik, D. Vuppalanchi, and U. P. Naik, Essential Role of Junctional Adhesion Molecule-1 in Basic Fibroblast Growth Factor-Induced Endothelial Cell Migration, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.12, pp.2165-2171, 2003.
DOI : 10.1161/01.ATV.0000093982.84451.87

S. L. Merklinger, P. L. Jones, E. C. Martinez, and M. Rabinovitch, Epidermal Growth Factor Receptor Blockade Mediates Smooth Muscle Cell Apoptosis and Improves Survival in Rats With Pulmonary Hypertension, Circulation, vol.112, issue.3, pp.423-431, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.540542

R. T. Schermuly, Reversal of experimental pulmonary hypertension by PDGF inhibition, Journal of Clinical Investigation, vol.115, issue.10, 2005.
DOI : 10.1172/JCI24838

S. Eddahibi, Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension, Journal of Clinical Investigation, vol.108, issue.8, pp.1141-1150, 2001.
DOI : 10.1172/JCI200112805

M. Schalling, A. Dagerlind, P. Stieg, C. Lindquist, and T. Hokfelt, Colocalization of neurotransmitters analyzed by in situ hybridization, European Neuropsychopharmacology, vol.1, issue.2, pp.173-176, 1991.
DOI : 10.1016/0924-977X(91)90720-F

T. Raj, Th-W60:5 Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice, Atherosclerosis Supplements, vol.7, issue.3, pp.1845-1851, 2006.
DOI : 10.1016/S1567-5688(06)81946-X

F. L. Carson, Histotechnology: a self-instructional text, 1997.